Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-28 4:42 pm Purchase |
2024-08-28 | 13G | Whitehawk Therapeutics Inc WHWK |
BML Investment Partners, L.P. | 1,383,817 5.600% |
1,383,817 (New Position) |
Filing History |
| 2023-02-13 5:39 pm Sale |
2022-12-31 | 13G | Whitehawk Therapeutics Inc WHWK |
Vivo Panda LLC | 509,572 2.100% |
-218,095 (-29.97%) |
Filing History |
| 2023-02-10 1:04 pm Purchase |
2022-12-31 | 13G | Whitehawk Therapeutics Inc WHWK |
Satter Muneer A | 1,630,830 6.700% |
336,045 (+25.95%) |
Filing History |
| 2023-01-17 4:59 pm Purchase |
2023-01-01 | 13D | Whitehawk Therapeutics Inc WHWK |
Desai Neil | 2,635,196 10.800% |
36,755 (+1.41%) |
Filing History |
| 2022-10-04 4:01 pm Purchase |
2022-09-26 | 13G | Whitehawk Therapeutics Inc WHWK |
Satter Muneer A | 1,294,785 5.300% |
1,294,785 (New Position) |
Filing History |
| 2022-09-26 5:27 pm Purchase |
2022-09-22 | 13D | Whitehawk Therapeutics Inc WHWK |
Avoro Capital Advisors LLC | 3,471,752 14.400% |
1,260,000 (+56.97%) |
Filing History |
| 2022-02-14 4:13 pm Purchase |
2021-08-26 | 13G | Whitehawk Therapeutics Inc WHWK |
Venrock Healthcare Capital Partners II, L.P. | 1,529,402 7.300% |
1,529,402 (New Position) |
Filing History |
| 2022-02-11 7:33 pm Sale |
2021-12-31 | 13G | Whitehawk Therapeutics Inc WHWK |
BIOTECHNOLOGY VALUE FUND L P | 899,392 4.300% |
-247,660 (-21.59%) |
Filing History |
| 2022-02-11 5:20 pm Sale |
2021-12-31 | 13G | Whitehawk Therapeutics Inc WHWK |
Vivo Panda LLC | 727,667 3.500% |
-113,504 (-13.49%) |
Filing History |
| 2022-02-09 3:15 pm Purchase |
2021-12-31 | 13G | Whitehawk Therapeutics Inc WHWK |
The Vanguard Group | 761,473 3.640% |
761,473 (New Position) |
Filing History |
| 2021-11-15 4:33 pm Sale |
2021-11-15 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
RA Capital Management, L.P. | 0 0.000% |
-165,749 (Position Closed) |
Filing History |
| 2021-11-12 4:03 pm Sale |
2021-11-10 | 13D | Whitehawk Therapeutics Inc WHWK |
Satter Muneer A | 374,785 1.790% |
-4 (-0.00%) |
Filing |
| 2021-09-08 5:30 pm Purchase |
2021-08-26 | 13D | Whitehawk Therapeutics Inc WHWK |
Desai Neil | 2,598,441 12.400% |
2,598,441 (New Position) |
Filing History |
| 2021-09-07 5:26 pm Purchase |
2021-08-26 | 13G | Whitehawk Therapeutics Inc WHWK |
BIOTECHNOLOGY VALUE FUND L P | 1,147,052 5.500% |
1,147,052 (New Position) |
Filing History |
| 2021-09-07 5:25 pm Purchase |
2021-08-26 | 13D | Whitehawk Therapeutics Inc WHWK |
ACUTA CAPITAL PARTNERS LLC | 1,548,081 7.300% |
1,548,081 (New Position) |
Filing History |
| 2021-09-03 4:47 pm Sale |
2021-08-26 | 13D | Whitehawk Therapeutics Inc WHWK |
ORBIMED ADVISORS LLC | 346,262 1.700% |
-1 (-0.00%) |
Filing |
| 2021-09-02 4:30 pm Purchase |
2021-08-26 | 13G | Whitehawk Therapeutics Inc WHWK |
Vivo Panda LLC | 841,171 4.000% |
841,171 (New Position) |
Filing History |
| 2021-08-30 5:27 pm Purchase |
2021-08-26 | 13D | Whitehawk Therapeutics Inc WHWK |
Avoro Capital Advisors LLC | 2,211,752 10.700% |
2,211,752 (New Position) |
Filing History |
| 2021-08-23 4:30 pm Purchase |
2021-08-11 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
RA Capital Management, L.P. | 165,749 5.220% |
60,762 (+57.88%) |
Filing History |
| 2021-07-12 4:30 pm Purchase |
2021-06-30 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
RA Capital Management, L.P. | 104,987 3.300% |
104,987 (New Position) |
Filing History |